YMAB EQUITY ALERT: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Y-mAbs Therapeutics, Inc. Investors with Losses to Inquire About Securities Class Action Investigation – YMAB
NEW YORK, Nov. 01, 2022 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB) resulting from allegations that Y-mAbs may have issued materially misleading business information to the investing public. SO WHAT: If you […]